TAF9 Recombinant Protein
Shipping Info:
For estimated delivery dates, please contact us at [email protected]
Amount : | 20 µg |
Purification : | Greater than 90% as determined by SDS-PAGE. |
Content : | TAF9 Human solution (0.5mg/1ml) containing 20mM Trsi HCL pH-8, 1mM DTT and 10% glycerol. |
Storage condition : | Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time.Please avoid freeze thaw cycles. |
AA sequence : | MGSSHHHHHH SSGLVPRGSH MLLPNILLTG TPGVGKTTLG KELASKSGLK YINVGDLARE EQLYDGYDEE YDCPILDEDR VVDELDNQMR EGGVIVDYHG CDFFPERWFH IVFVLRTDTN VLYERLETRG YNEKKLTDNI QCEIFQVLYE EATASYKEEI VHQLPSNKPE ELENNVDQIL KWIEQWIKDH NS |
Alternative Name : | TAF9 RNA polymerase II TATA box binding protein (TBP)-associated factor 32kDa, TAFII32, AK6, CINAP, TAFII31, TAF2G, CGI-137, MGC1603, MGC3647, MGC5067, TAFIID32, Coilin-interacting nuclear ATPase protein, Transcription initiation factor TFIID 31/32 k |
Source : Escherichia Coli.
TAF9 produced in E.Coli is a single, non-glycosylated polypeptide chain containing 192 amino acids (1-172.a.a) and having a molecular mass of 22.2kDa. TAF9 is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
TAF9 is a universal transcription factor which enables the preinitiation complex assembly by direct interactions with the TATA promoter element. TAF9 is a multisubunit complex consisting of a small TATA-binding polypeptide and other TBP-associated factors (TAFs) and performs as a channel for regulatory signals.
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
There are currently no product reviews
|